ARCA biopharma, Inc. Uncategorized Contracts & Agreements
62 Contracts & Agreements
- Form of Amendment (Filed With SEC on July 9, 2024)
- Director Offer Letter, dated April 24, 2024, between Oruka Therapeutics, Inc. and Kristine Ball (Filed With SEC on May 14, 2024)
- Amended and Restated Director Offer Letter, dated March 22, 2024, between Oruka Therapeutics, Inc. and Samarth Kulkarni (Filed With SEC on May 14, 2024)
- Form of Lock-Up Agreement (Filed With SEC on April 3, 2024)
- Form of Oruka Support Agreement (Filed With SEC on April 3, 2024)
- Form of ARCA Support Agreement (Filed With SEC on April 3, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 18, 2020)
- Letter Agreement between ARCA biopharma, Inc. and Medtronic, Inc. dated as of April 17, 2018 (Filed With SEC on April 23, 2018)
- Amendment to European Addendum to the Clinical Trial Agreement Between Medtronic and ARCA dated July 10, 2017 (Filed With SEC on November 9, 2017)
- Change Order Form (Filed With SEC on November 12, 2015)
- Change Order Form (Filed With SEC on November 12, 2015)
- Change Order Form (Filed With SEC on May 12, 2015)
- Change Order Form (Filed With SEC on November 12, 2014)
- 8001 Arista Place, Suite 200 Broomfield, CO 80021 Phone: 720 ###-###-####, Fax: 720 ###-###-#### March 31, 2011 (Filed With SEC on April 5, 2011)
- 8001 Arista Place, Suite 200 Broomfield, CO 80021 Phone: 720 ###-###-####, Fax: 720 ###-###-#### January 20, 2011 (Filed With SEC on January 26, 2011)
- 8001 Arista Place, Suite 200 Broomfield, CO 80021 Phone: 720 ###-###-####, Fax: 720 ###-###-#### December 21, 2010 (Filed With SEC on December 22, 2010)
- 8001 Arista Place, Suite 200 Broomfield, CO 80021 Phone: 720 ###-###-####, Fax: 720 ###-###-#### December 8, 2010 (Filed With SEC on December 14, 2010)
- SECTION 1. DEFINITIONS (Filed With SEC on March 4, 2010)
- ARCA BIOPHARMA, INC. EQUITY DISTRIBUTIONAGREEMENT (Filed With SEC on December 8, 2009)
- NOTICE OF OPTION AMENDMENT (Filed With SEC on August 10, 2009)
- ARCA BIOPHARMA, INC. 2009 REDUCTION IN FORCE (Filed With SEC on August 10, 2009)
- UNIVERSITY OF COLORADO MATERIALS TRANSFER AGREEMENT (Filed With SEC on May 15, 2009)
- 8001 Arista Place, Suite 200 Broomfield, CO 80021 Phone: 720 ###-###-####, Fax: 720 ###-###-#### (Filed With SEC on May 15, 2009)
- 1200 17th Street, Suite 620 Denver, Colorado 80202 Phone: 303 ###-###-####, Fax: 303 ###-###-#### July 27, 2007 (Filed With SEC on May 15, 2009)
- PATHEON PROPOSAL :ARC-FYM1-0800-0406-R5 (Filed With SEC on May 15, 2009)
- INDEMNITY AGREEMENT (Filed With SEC on March 27, 2009)
- AMENDMENT NO. 6 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- AMENDMENT NO. 5 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- AMENDMENT NO. 4 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- AMENDMENT NO. 3 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- AMENDMENT NO. 2 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- AMENDMENT NO. 1 TO THE ARCA DISCOVERY, INC. (Filed With SEC on January 28, 2009)
- Programme Amendment Order (Filed With SEC on March 12, 2008)
- Nuvelo, Inc. Base Salary for Named Executive Officer Effective August 1, 2007 (Filed With SEC on September 19, 2007)
- Page 1 of 10 (Filed With SEC on July 6, 2007)
- Nuvelo, Inc. Base Salaries for Named Executive Officers Effective August 1, 2006. (Filed With SEC on August 3, 2006)
- 675 Almanor Avenue, Sunnyvale, CA 94085 tel: 408 ###-###-#### fax: 408 ###-###-#### www.nuvelo.com (Filed With SEC on March 15, 2006)
- NUVELO, INC. (Filed With SEC on January 31, 2006)
- 675 AlmanorAvenue, Sunnyvale, CA 94085 tel: 408 ###-###-#### fax: 408 ###-###-#### www.nuvelo.com (Filed With SEC on November 8, 2005)
- KINGSBRIDGE CAPITAL LIMITED and NUVELO, INC. dated as of August 4, 2005 TABLE OF CONTENTS (Filed With SEC on August 5, 2005)
